tradingkey.logo
tradingkey.logo
Search

Precision Biosciences Receives U.S. FDA Fast Track Designation For Pbgene-Hbv

ReutersApr 15, 2025 11:22 AM
facebooktwitterlinkedin

- Precision BioSciences Inc DTIL.O:

  • PRECISION BIOSCIENCES RECEIVES U.S. FDA FAST TRACK DESIGNATION FOR PBGENE-HBV, A FIRST-IN-CLASS GENE EDITING THERAPY DESIGNED TO ELIMINATE THE ROOT CAUSE OF CHRONIC HEPATITIS B

Disclaimer: The information provided on this website is for educational and informational purposes only and should not be considered financial or investment advice.

Recommended Articles

Tradingkey
KeyAI